TSPAN1 and colorectal carcinoma: To date, the liquid chromatography–tandem mass spectrometry (LC–MS/MS) analysis of HTC116-derived and HT29-derived small EVs revealed that TSPAN1 is a potent non-invasive biomarker for CRC detection [23].